2024 Annual Meeting Presentations

MASCC Fellows Q&A – Prof Alexandre Chan

Eye Toxicities from Targeted Cancer Therapies: An Emerging Supportive Care Need – Dr Neel Pasricha

My Meandering Melanoma – Dr John McNorton (Patient Partner)

Immune Effector Cell-associated Neurotoxicity Syndrome (ICANS) and Hypophosphatemia Post-chimeric Antigen Receptor (CAR) T-cell Therapy – Dr Doreen Pon

Cardio-Oncology Quality Improvement with Risk Stratification by Lactic Acidosis in STEMI: National AI Analysis of 342,400 Hospitalizations – Prof Cezar Iliescu

Advancing Care in Cancer-Associated Thrombosis: Addressing Gaps and Future Directions – Dr Alok Khorana

Unlocking the Potential of Direct Oral Anticoagulants in Cancer-Associated Thrombosis: Navigating Indications and Hurdles – Dr Loula Papageorgiou

Hemostasis Radiotherapy for Inoperable Gastric Cancer: A Prospective Phase 2 Study – Prof Osamu Tanaka

Risk Assessment Model to Predict Venous Thromboembolism in Colorectal Cancer Outpatients. CARTAGO Sub-Study – Mrs Marta Merino

ACT for Patients With Active Cancer and High Thromboembolic Risk: Results From the ACT4CAT Study – Dr Nikolaos Tsoukalas

The Development and Impact of Patient Advocacy in the UK – Mrs Lesley Turner

Psychosexual Educational Partners Program (PEPP): A Feasibility Study –  Dr Noel Arring

Time to Make Metastatic Breast Cancer Count: Outcomes of a National Roundtable and Consumer-Led Advocacy – Ms Vicki Durston

Integrating A Patient Partner in an Oncology Day Care Unit at AP-HP – Dr Antoine Smulevici

MASCC-ESMO Guidelines: The 2023 Update – Prof Jørn Herrstedt 

New Anticancer Drugs Related Nausea and Vomiting: How to Manage Them – Dr Didier Mayeur

Patients’ Voice Matters: Patient-Reported Outcomes for Chemotherapy-Induced Nausea and Vomiting in a Randomized Controlled Trial – Dr Kritthivasan Venkatakrishnan

Antiemetic Medications for Preventing Chemotherapy-Induced Nausea and Vomiting in Children. A Systematic Review and Bayesian Network Meta-Aanalysis – Ms Ruth Walker

Adaptation of Clinical Practice Guidelines on Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer Patients for Use in France – Miss Marie Charlotte Renaux Torres

Genomic Underpinnings of Treatment Induced Nausea in Women with Breast Cancer – A Longitudinal Study – Dr Susan Wesmiller

Impact of New-Generation Hormone Therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer – Mr Antoine Boué (Outstanding Young Investigator Award sponsored by Fondation Santé Service)

Concordance of Patient- and Clinician-Reported Outcomes in Acute Radiation Dermatitis in Breast Cancer – Miss Milena Gojsevic

Radiation Fractionation in Breast Cancer: Systematic Review and Meta-Analysis with Emphasis on Side Effects and Cosmesis – Miss Samantha K. F. Kennedy

Patient-Initiated vs Physician-Initiated Response to Patient-Reported Symptom Monitoring: Completion Rates and Alert-Handling in the SYMPRO-LUNG Trial – Mrs Nicole Billingy

Association Between Social Determinant of Health Profiles and Psychological Distress Among US Cancer Survivors: A Unsupervised Clustering Analysis – Ms Fangyuan Chen

Assessing the Quality of Life in Older Persons With Cancer Undergoing Radiotherapy, During and One Year Post-Treatment – Dr Edna Darlene Rodrigues (AICSO-MASCC Young Investigator Award)

Digital Interventions in Supportive Care, Are We Leaving Older People Behind? – Dr Enrique Soto

Using Supportive Digital Interventions in Low- and Middle-Income Contexts: A Vietnam Case Study – Dr Olinda Santin

A Better Way to Predict Chemotherapy Toxicity in Colonic Cancer Patients – Dr Ke Cao

Digital Health Technology Use Among People Diagnosed With Cancer Aged 55 Years and Over: Findings From the 45 and Up Study – Dr David Mizrahi

Overview of Large-Scale Implementation of Electronic Patient-Reported Outcome Measures (ePROMs) into Routine Oncology Care – Prof Janelle Yorke

Predicting Psychosocial Needs Using Natural Language Processing – Dr John-Jose Nunez

Work After Cancer: The Global Perspective – Prof Bogda Koczwara

The Challenges of Employment After Cancer in Underrepresented Populations and How to Address Them – Dr Saskia Duijts

Cultural Considerations of Working After Cancer and Tailored Intervention – Dr Juhee Cho

Self-reported Mental Health and Work Leave among Employed Breast Cancer Survivors – Mrs Jasmin Hundal

Cognitive Difficulties and Return to Work in Breast Cancer Patients 2 Years After Diagnosis – Dr Marie Lange

Feasibility Study of a Rehabilitation Intervention to Support Women Diagnosed with Breast Cancer to Return to Work Post Active Treatment – Dr Moira O’Connor

Years of Life Loss and Productivity Loss in Long-Term Cancer Survivors – Prof Bogda Koczwara

Addressing the Fatigue Symptom Cluster – Effective Strategies to Concomitantly Influence Pain, Nausea, Sleep Dysfunction, and Anxiety – Prof Florian Strasser

Models of Care to Address Symptom Clusters Affecting Cancer-Related Fatigue: Implementation Lessons for Low and Middle Resource Nations – Prof Carmen Escalante

The Mediating Effect of Insomnia on Cancer-Related Fatigue Among Cancer Survivors: A URCC NCORP Phase III RCT of Yoga and Cognitive Behavioral Therapy – Dr Po-Ju Lin

Physical Activity and Dexamethasone on Cancer Related Fatigue: A Preliminary Placebo Controlled Randomized Double-Blind Trial – Prof Sriram Yennu (MASCC 2024 Steven M Grunberg Memorial Lecture)

Evaluating the Effect of Yoga Intervention to Improve Shoulder Range of Motion Following Breast Cancer Treatment: A Randomized Controlled Trial – Prof Wendy Wing Tak Lam

How Does MASCC Tailor Guidelines for Resource-Limited Settings in Management of Acute Toxicities? CINV as a Case Study – Dr Snezana Bosnjak

How Does MASCC Tailor Guidelines for Resource-Limited Settings in Survivorship Care? – Prof Raymond Chan

Financial Hardship, Food Insecurity, and Care Access Barriers Among US Cancer Survivors With Financial Barriers to Care – Dr Changchuan Jiang

Resilience Related to Anxiety, Self-Esteem, and Internalized LGBTQ+ Negativity: A Stepwise Regression Model Among LGBTQ+ Cancer Survivors – Dr Viktor Clark

Perspectives of Cancer Survivors Living in Rural Settings: Challenges, Positive Experiences and Suggestions for Improvements in Survivorship Care – Prof Margaret Fitch

Findings From a Global Survey of Oncology Health Care Professionals on the Impact of Climate Change and Climate Disasters on Oncology Care – Ms Milagros Elia

Climate Change and Climate Disasters: What Oncology Health Care Professionals Need and Want to Know. A UK perspective – Mrs Rose Gallagher

Factors Determining the Implementation of an Intervention Promoting Medication Self-Management for Patient Treated With Oral Anticancer Drugs – Ms Sophie Groux

Evaluation of Our Management Circuit for Immune-Related Adverse Events in Patients With Non-Metastatic Triple-Negative Breast Carcinoma – Dr Alexandra Forestier

Health After Cancer: An Innovative Educational Portfolio About Cancer Survivorship for Patients and Healthcare Professionals – Prof Lidia Schapira

Oral Chronic Graft versus Host Disease – Current and Future Perspectives – Assoc Prof David Dean

Graft Versus Host Disease – Innovative Therapies – Prof Nicole Blijlevens

Subjective Oral Dryness Following Haematopoietic Cell Transplantation: A Report From the ORASTEM Study – Ms Marjolein S. Bulthuis

Oral Care in High Volume Tertiary Care Cancer Centre – Dental Hygienist Perspective – Ms Seema Prabhu

Delivering High Quality Supportive Care in Pediatric Hematology/Oncology – Dr Jason Freedman

Optimizing Clinical Care Through Digital Health: An e-Health Application to Improve Pain Management in the Home Setting for Children with Cancer – Prof Wim Tissing

Utilizing Epigenetic Ageing Metrics to Quantify Biological Changes in Adolescent and Young Adult Cancer Patients Over Time – Dr Michael Sayer

Culinary Nutrition for Caregivers: Improving Pediatric Cancer Patient and Caregiver Outcomes Through Nutrition and Culinary Support – Dr Brandy-Joe Milliron

Implementing Group Medical Visits in Multidisciplinary Cancer Survivorship – Dr Ines Vaz-Luis

Role of Telehealth Delivered GMV in Delivery of Equitable Survivorship Care – Dr Niharika Dixit

Cost-Effectiveness of a Cardio-Oncology Rehabilitation Framework for Cancer Survivors With High Cardiovascular Risk: Results From the CORE Trial – Dr Sofia Viamonte

Factors Influencing Cancer Survivors’ Experiences with Follow-up Cancer Care: Results from the Pan-Canadian Cancer Transitions Survey Study – Dr Amirrtha Srikanthan

Implementability of the DEFACTO2 3-Month Multimodal Program for Active Behaviour in People Living Beyond Cancer – Dr Aude-Marie Foucaut

Developing a Global Practice Framework for Cancer Navigation – Dr Imogen Ramsey

Introduction – Prof Joel Epstein & Dr Hannah Wardill 

Oncogastroenterology: Applying and Adapting Fundamentals of Gastroenterology to Address Gastrointestinal Complications of Cancer Treatment – Dr Darren Fernandes

Important Clinical Considerations to Optimize Diet and Nutritional Support in People with Mucositis – Prof Riva Touger-Decker

Effects of Oral Intake and Physical Symptoms on Prognoses of Cancer Patients Admitted to a Palliative Care Unit – Asst Prof Tetsuya Ito

Multi-Institutional, Randomized, Controlled Trial to Assess the Efficacy and Tolerability of a Reusable, Self-contained Cryotherapy Delivery Device – Dr Richard Zuniga

Participant Satisfaction and Experience With a Virtually Supervised Exercise Program for People With Advanced Cancer and Cachexia – Dr Eva Zopf

Demoralization is Not the Same as Depression – Prof Anja Mehnert-Theuerkauf

Neuropathic Pain and Depression Are Close Cousins: Treatment Tailored to Both – Dr Guillaume Pierre Serge Economos

Methadone Versus Other Opioids for Refractory Malignant Bone Pain: A Pilot Randomised Controlled Study – Dr Merlina Sulistio

Value Assessment of Acupuncture for Treating Cancer Pain: A Real-World Claims Database Analysis – Ding Quan Ng

Secondary Effects of Prophylactic Naldemedine Administration on Opioid- Induced Nausea and Vomiting in Patients With Cancer Pain – Dr Takahiro Higashibata

Early Palliative Care for Patients with Metastatic Upper Gastrointestinal Cancers: Results of the Multicentre Randomised Controlled EPIC Trial – Dr Pierre-Yves Cren

Introducing the Gut-Brain Axis – A Complex Network with Enormous Influence on Neuropathology – Dr Sofia Cussotto

Gut-Brain Axis Dysfunction and its Involvement in Neuropsychological Symptoms in People Undergoing Cancer Treatment: What is the Evidence? – Assoc Prof Jinbing Bai

Metabolomic Profiling of Saliva Predicts Risk of Diarrhoea and Cognitive Impairment in People With Breast cancer – Dr Courtney Cross

Gut-Brain-Axis Dysfunction in Paediatric Graft vs Host Disease – Maya Davies

Perturbations in Gut Microbiota Composition in Gynecologic Cancer Patients with Depressive Symptoms: a Longitudinal Study – Dr Deborah Watkins Bruner

Dissecting the Causal Contribution of the Gut Microbiota to the Neurological and Gastrointestinal Side Effects of the Myeloma Drug, Bortezomib – Ms Jacqui Scott

Web-Based Geriatric Assessment for Older Adults with Cancer and Multimorbidity – Prof Martine Puts

Changes in Frailty Among Older Cancer Survivors: A Longitudinal Cohort Study – Dr Denise Shuk Ting Cheung

Time Toxicity of Palliative Systemic Therapy Among Older Patients With Cancer – Joosje Baltussen

A Pilot Study to Examine the Feasibility and Safety of an Anti-Inflammatory Epigallocatechin Gallate (EGCG) Intervention in Older Survivors of Cancer – Dr Nikesha Gilmore

Chemotherapy-Induced Peripheral Neuropathy (CIPN): From Preclinical Data to Improvement of Patients’ Experience – Prof David Balayssac

Chemotherapy-Related Cognitive Impairment (CRCI): From Preclinical Data to Improvement of Patients’ Experience – Dr Florence Joly

Association Between Cognitive Function and Physical Function, Frailty, and Quality of Life in Older Cancer Survivors –  Diane Von Ah

Safety and Efficacy of Limb Cryocompression to Prevent Chemotherapy Induced Peripheral Neuropathy in Patients Receiving Taxane-Based Chemotherapy – Dr Rachel SJ Wong

Association of Cytokines and Brain-Derived Neurotrophic Factor with Self-Reported Cognitive Impairment in Adolescent and Young Adult Cancer Patients – Julia Trudeau

Introduction – Dr Niharika Dixit & Prof Joel Epstein

The MASCC DPYD Testing Guidelines –Rationale and Ongoing Work – Dr Fabienne Thomas

MUCILIGHT Trial: Phase 2 of LED Photobiomodulation for Treatment of Mucositis in Oral Cavity or Oropharyngeal Cancer – Dr Xavier Liem

Intralesional Corticosteroid Therapy for Management-Resistant Radiation Induced Oropharyngeal Mucositis – Dr Muhammad Ali Shazib

The Landscape of Supportive Oncology: Current Status of Clinical Services – Dr Ye Aung

Supportive Care (SC) Structures and Fundings in French Comprehensive Cancer Centers (CCC): A National Survey – Mrs Clémence Dancoisne

Early Supportive Care vs Standard Care in Cancer Patients Included in Phase 1 Clinical Trials. A Psychosocial-Approched Clinical Trial – Miss Claudia Cruz Sequeiros

Patterns of Emergency Department Visits Among Patients With Breast and Gynecological Cancer: Gaps and Opportunities – Dr Yu Ke

Comparison of Physical Therapy Care With Negative Pressotherapy Versus Manual Massages on Pain and Functional Impairment After a Total Mastectomy – Dr Claudia Regis

Five-Year Follow-Up of the OptiTrain Trial on Concurrent Resistance and High-Intensity Interval Training During Chemotherapy for Patients With Breast Cancer – Dr Poorna Anandavadivelan

Society for Integrative Oncology Anxiety and Depression Clinical Practice Guidelines in Adults Living With Cancer – Process and Update – Dr Suzanna Zick